-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Akero Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2022 to 2024.
- Akero Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2025 was $1.17M, a 4.79% decline year-over-year.
- Akero Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2025 was $4.77M, a 19.1% increase year-over-year.
- Akero Therapeutics, Inc. annual Interest Expense for 2024 was $4.67M, a 50.6% increase from 2023.
- Akero Therapeutics, Inc. annual Interest Expense for 2023 was $3.1M, a 319% increase from 2022.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)